EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unleashing viral mimicry: A combinatorial strategy to enhance the efficacy of PARP7 inhibitors

Patrick Manetsch, Michael O Hottiger iD

BioEssays · 2025

DOI: 10.1002/bies.202400087 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BioEssays, 2025. Verfasst von Patrick Manetsch und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Mechanisms of Disease, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Neoplasms, Poly(ADP-ribose) Polymerase Inhibitors, Poly(ADP-ribose) Polymerases, Molecular Mimicry. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canton of Zurich and the Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cells exploit mechanisms to evade immune detection triggered by aberrant self‐nucleic acids (NA). PARP7, a key player in this immune evasion strategy, has emerged as a potential target for cancer therapy. PARP7 inhibitors reactivate NA sensing, resulting in type I interferon (IFN) signaling, programmed cell death, anti‐tumor immunity, and tumor regression. Cancer cells with elevated IFN‐stimulated gene (ISG) scores, representing a viral mimicry‐primed state, are particularly sensitive to PARP7 inhibition. This review focuses on the endogenous sources of NA in cancer and the potential to exploit elevated aberrant self‐NA in cancer therapy. We describe strategies to increase cytoplamic NA levels, including targeting epigenetic control, DNA damage response, and mitochondrial function. We also discuss targeting RNA processing pathways, such as splicing and RNA editing, to enhance the immunostimulatory potential of existing NA. Combining PARP7 inhibitors with NA elevating strategies may improve cancer immunotherapy, especially for tumors with high ISG scores.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsPoly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) PolymerasesMolecular MimicryHumansAnimalsImmunotherapySignal Transduction

Stichwörter der Autor:innen

FRA1PARP7anti‐tumor immunitycancer therapyprogrammed cell deathviral mimicry

Substanzen

Poly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) Polymerases

Autor:innen und Institutionen

  • Department of Molecular Mechanisms of Disease, University of Zurich, Zurich, Switzerland.
  • Molecular Life Science PhD Program of the Life Science Zurich Graduate School, University of Zurich, Zurich, Switzerland.

ORCID-Profile: Michael O Hottiger

Förderung

  • Canton of Zurich and the Swiss National Science Foundation

Zitieren

APA

Manetsch, P., & Hottiger, M. O. (2025). Unleashing viral mimicry: A combinatorial strategy to enhance the efficacy of PARP7 inhibitors. BioEssays. https://doi.org/10.1002/bies.202400087

Vancouver

Manetsch P, Hottiger MO. Unleashing viral mimicry: A combinatorial strategy to enhance the efficacy of PARP7 inhibitors. BioEssays. 2025. doi:10.1002/bies.202400087

BibTeX
@article{Manetsch2025,
  author = {Manetsch, Patrick and Hottiger, Michael O},
  title = {Unleashing viral mimicry: A combinatorial strategy to enhance the efficacy of PARP7 inhibitors},
  journal = {BioEssays},
  year = {2025},
  doi = {10.1002/bies.202400087}
}
Kostenlos starten →